Welcome to our dedicated page for GE Aerospace news (Ticker: GE), a resource for investors and traders seeking the latest updates and insights on GE Aerospace stock.
GE Aerospace (NYSE: GE) is a global aerospace propulsion, services, and systems company with an installed base of tens of thousands of commercial and military aircraft engines. The GE news feed on Stock Titan highlights official announcements, customer agreements, technology collaborations, and capital markets disclosures that shape the company’s role in aviation.
News items often feature engine selection and purchase agreements with airlines and aviation groups for families such as GEnx and GE9X, including orders that cover engines, spare units, and long-term services support. These stories provide insight into how airlines are planning fleet growth, widebody expansion, and long-haul route development using GE Aerospace propulsion.
Investors and aviation followers will also find coverage of service and leasing partnerships, such as lease pool management arrangements for GE9X, GEnx, GE90, CF6, and CF34 engines. These updates explain how GE Aerospace and its partners manage shop visits, lease returns, and technical support to keep fleets operating reliably.
The news stream includes technology and innovation updates, including collaborations to develop hybrid electric turbogenerators for Advanced Air Mobility and work on integrated hybrid electric propulsion systems. Announcements about defense propulsion, such as the use of F110 engines and propulsion support for autonomous VTOL aircraft, highlight the company’s presence in military and next‑generation applications.
Additional releases cover corporate actions such as regular quarterly dividend declarations, leadership changes disclosed via SEC filings, and community and education initiatives, including scholarship programs supported by the GE Aerospace Foundation. For readers tracking GE Aerospace, this news page offers a centralized view of customer deals, technology milestones, governance developments, and strategic partnerships. Bookmark this page to monitor how GE Aerospace’s engine programs, services, and collaborations evolve over time.
GE announced the brand names for its future companies following its planned separation into three entities: GE HealthCare for healthcare, GE Vernova for energy, and GE Aerospace for aviation. Each company will leverage GE's $20 billion global brand value. GE HealthCare will be listed on Nasdaq under the symbol GEHC, focusing on innovation in healthcare. GE Vernova will be tasked with sustainable energy solutions and is set for spin-off in early 2024. GE Aerospace will support the aviation sector, maintaining a strong presence with over 39,000 aircraft engines worldwide.
GE announced significant leadership changes at GE Aviation, effective immediately. H. Lawrence Culp, Jr. becomes CEO of GE Aviation while maintaining his role as Chairman and CEO of GE. John Slattery transitions to Executive VP and Chief Commercial Officer. Russell Stokes is promoted to President and CEO of Commercial Engines and Services, while Rahul Ghai joins as CFO. This restructuring follows GE's plan to split into three independent companies focusing on Aviation, Healthcare, and Energy, addressing unprecedented demand and preparing for GE Aviation's transition to a standalone public entity.
IonQ (NYSE: IONQ) and GE have reported early results from their collaboration, demonstrating the application of quantum computing in risk management. They have effectively used quantum models to analyze multi-variable distributions, outperforming classical approaches in some instances. This research holds potential benefits for various sectors including finance and supply chain management. Advances in quantum methodologies may improve decision-making and risk assessment amid volatile market conditions.
GE Healthcare unveiled Portrait Mobile, a wireless patient monitoring system that allows continuous monitoring during hospital stays. This technology aims to detect patient deterioration earlier than traditional methods, potentially reducing ICU admissions and length of stay. The system captures vital signs wirelessly, enabling better patient mobility and early intervention for complications. Developed at GE's center in Helsinki, Portrait Mobile ensures reliable monitoring, leveraging existing hospital networks and improving overall patient outcomes.
The Board of Directors of GE (NYSE: GE) has declared a $0.08 per share dividend on the company's outstanding common stock. This dividend is scheduled for payment on July 25, 2022 to shareholders of record as of the close of business on June 28, 2022. The ex-dividend date is set for June 27, 2022. GE continues to focus on delivering reliable and efficient solutions while maintaining strong engagement with stakeholders.
At the SNMMI 2022 Annual Meeting, GE Healthcare unveiled advanced molecular imaging solutions for prostate cancer, including a new Solid Target Platform for increased Gallium-68 production. This marks the 500th installation of their cyclotron, enhancing access to critical radioisotopes used in PET imaging. The company emphasizes the role of theranostics in personalized cancer care, especially after FDA approvals for relevant therapies like Lutetium-177 PSMA-617. GE Healthcare aims to improve patient outcomes and facilitate dedicated theranostics centers globally.
GE Digital has achieved AWS Energy Competency status, demonstrating its expertise in leveraging AWS technology for the energy sector. This recognition highlights GE Digital’s Asset Performance Management (APM) software, designed to enhance the performance, reliability, and cost-efficiency of energy production. The APM solutions are critical as energy industries transition towards more renewable sources. The AWS partnership enables GE Digital to further support clients in achieving their energy transition goals.
GE Healthcare is enhancing cancer care through strategic collaborations, aiming to improve patient outcomes and clinical efficiency. The company has partnered with various organizations, including RaySearch and Elekta, to integrate imaging and radiation solutions. These efforts focus on precision medicine, utilizing AI and data analytics to streamline oncology treatments. Highlights include advancements in radiation therapy planning and the introduction of innovative diagnostic tools. GE Healthcare operates in a $17.7 billion market, emphasizing its commitment to multidisciplinary cancer care.
GE Healthcare and Medtronic announced the FDA 510(k) clearance and CE Mark approval for integrating their advanced Microstream™ capnography and INVOS™ regional oximetry technologies into the CARESCAPE precision monitoring platform. This collaboration aims to enhance patient outcomes by providing real-time, continuous monitoring, which helps in predicting and preventing perioperative complications. The integration supports improved clinical efficiency, safety, and quality of care, ultimately aiding clinicians in delivering personalized patient care.
FAQ
What is the current stock price of GE Aerospace (GE)?
What is the market cap of GE Aerospace (GE)?
